Literature DB >> 7922293

Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease.

J O Connolly1, R M Higgins, H L Walters, A D Mackie, P L Drury, B M Hendry, J E Scoble.   

Abstract

Atherosclerotic renovascular disease (ARD) is an increasingly important cause of renal failure. However, important features of the clinical presentation are not fully described, and the outcome after intervention by angioplasty remains controversial. Ninety-four patients with ARD diagnosed at angiography were reviewed. Twenty-four patients were diabetic. Thirty-nine patients had unilateral renal artery stenosis or occlusion (group A), 28 had bilateral stenosis (group B), and 27 had unilateral occlusion plus contralateral occlusion or stenosis (group C). Two years after presentation, actuarial patient survival was 96%, 74.3% and 47.1% in groups A, B and C, respectively (p < 0.001 for all differences); actuarial renal survival in surviving patients was 97.3%, 82.4% and 44.7%, respectively (p < 0.001 for all differences). Percutaneous transluminal balloon angioplasty (PCTA) was performed in 74 patients. Renal function improved in only a minority of cases, but was stable in 73% of nondiabetic patients 12 months after PCTA. Angioplasty was less effective in diabetic subjects, with only 53.3% having stable renal function at 12 months follow-up. Renal and patient survival were strongly related to the initial angiographic findings. In non-diabetic subjects, PCTA resulted in stabilization of renal function for at least one year in nearly three-quarters of cases, which suggests a benefit from intervention in this disease whose natural history is otherwise of progression.

Entities:  

Mesh:

Year:  1994        PMID: 7922293

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  6 in total

Review 1.  Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention.

Authors:  R G Woolfson
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

Review 2.  Renovascular hypertension: screening and modern management.

Authors:  Iris Baumgartner; Lilach O Lerman
Journal:  Eur Heart J       Date:  2011-01-27       Impact factor: 29.983

Review 3.  Atherosclerotic renal artery stenosis: surgery, percutaneous transluminal angioplasty, or medical therapy?

Authors:  P F Plouin; B Guéry; A La Batide Alanore
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 4.  Atherosclerotic stenosis of the renal arteries. Indications for intervention.

Authors:  M R Jaff; J W Olin
Journal:  Tex Heart Inst J       Date:  1998

5.  Arterial stents in the management of neurofibromatosis and renovascular hypertension in a pediatric patient: case report of a new treatment modality.

Authors:  F F Ing; B Goldberg; D H Siegel; H Trachtman; F Z Bierman
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Nov-Dec       Impact factor: 2.740

6.  The importance of proteinuria and prior cardiovascular disease in all major clinical outcomes of atherosclerotic renovascular disease - a single-center observational study.

Authors:  Diana Vassallo; James Ritchie; Darren Green; Constantina Chrysochou; Joseph Blunt; Philip A Kalra
Journal:  BMC Nephrol       Date:  2016-12-07       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.